Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group ( GHSG ) phase‐I trial-Reference-Cited by-同舟云学术

Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group ( GHSG ) phase‐I trial

Published:2018-12-28 Issue:1 Volume:185 Page:42-52
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Böll Boris¹^ORCID,Plütschow Annette¹,Bürkle Carolin¹,Atta Johannes²,Pfreundschuh Michael³,Feuring‐Buske Michaela⁴,Vogelhuber Martin⁵,Sökler Martin⁶,Eichenauer Dennis A.¹,Thielen Indra¹,Tresckow Bastian¹^ORCID,Fuchs Michael¹,Engert Andreas¹,Borchmann Peter¹,

Affiliation:

1. German Hodgkin Study Group (GHSG) Department of Internal Medicine 1 University Hospital Cologne CologneGermany

2. Haematology Oncology University Hospital Frankfurt FrankfurtGermany

3. Haematology Oncology University Hospital Saarland HomburgGermany

4. Haematology Oncology University Hospital Ulm UlmGermany

5. Haematology Oncology University Hospital Regensburg RegensburgGermany

6. Haematology Oncology University Hospital Tübingen Tübingen Germany

Funder

Celgene

Publisher

Wiley

Subject